Pison has announced the results of a recent clinical trial conducted by researchers at the Temple MDA/ALS Center of Hope, which concluded that the company’s Neural Biosensor hardware and electroneurography (ENG) technology was able to distinguish patients with ALS from those without the condition and detect changes in surface electromyography in those with ALS – reflecting motor neuron changes correlated with functional changes. The study was led by Terry Heiman-Patterson, MD, Professor of Neurology at the Lewis Katz School of Medicine at Temple University and Director of the Temple MDA/ALS Center of Hope. The Associated Press highlighted the news and included comments from Dr. Heiman-Patterson.
Temple Faculty Physicians is experiencing technical issues with phone lines. If you are experiencing an emergency, please visit your nearest emergency room. If you would like to schedule an appointment with your provider or have general questions or requests, please contact us by using myTempleHealth.
myTempleHealth
800-TEMPLE-MED
Schedule Appointment
SEARCH TEMPLE HEALTH